Stay up to date with the latest developments in therapeutics by reading the world’s most respected source of authoritative drug information. For over 40 years Drugs has been the definitive journal of drugs and therapeutics, providing independent and crucial information authored by leading international clinicians and researchers.
Our prestigious and truly international Honorary Editorial Board ensures content of the highest quality to support clinical decision-making.
Through a rigorous and comprehensive program of peer-reviewed evaluations, Drugs provides detailed and objective analysis covering the full spectrum of new and established drug therapies in all disease areas.
- 75 Volumes
- 757 Issues
- 7,760 Articles
- 39 Open Access
- 1971 - 2015 Available between
Sarah L. Greig (August 2015)
New and Emerging Agents for the Treatment of Hemophilia: Focus on Extended Half-Life Recombinant Clotting Proteins
Margaret V. Ragni (August 2015)
- Journal Title
- Volume 1 / 1971 - Volume 75 / 2015
- Print ISSN
- Online ISSN
- Springer International Publishing
- Additional Links
- Industry Sectors
To view the rest of this content please follow the download PDF link above.